UCB Biopharma S.P.R.L. clinical trials

A subsidiary of UCB S.A.

The registry lists 48 studies whose lead sponsor is UCB Biopharma S.P.R.L.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 19, 2023.

Studies

Recruiting first, then most recently updated. Showing 48 of 48. All UCB S.A. studies →

• Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant EpilepsyCompletedNCT03373383Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT03861481Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994CompletedNCT02582866Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing SpondylitisCompletedNCT02963506Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory ArthritisCompletedNCT02969525Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure ClustersTerminatedNCT01529034Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisCompletedNCT02905006Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With EpilepsyCompletedNCT03405714Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic PsoriasisCompletedNCT03051217Phase 2/3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study ParticipantsCompletedNCT03859219Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset SeizuresCompletedNCT02687711

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia GravisCompletedNCT03052751Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic FunctionTerminatedNCT04136444Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)CompletedNCT02346240Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of PadsevonilCompletedNCT03480243Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study ParticipantsCompletedNCT04075409Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study ParticipantsCompletedNCT04013191Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus ErythematosusCompletedNCT02804763Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Cardiac Effects of Padsevonil in Healthy Study ParticipantsTerminatedNCT04126343Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or CannabidiolTerminatedNCT04039919Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD)CompletedNCT04875962Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary GeneralizationCompletedNCT03685630Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit SettingCompletedNCT03021018Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy SubjectsCompletedNCT03895385Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer ParticipantsCompletedNCT03707717Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilCompletedNCT03695094Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326298Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic SeizuresNo longer availableNCT03559673

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersTerminatedNCT01390220Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure ClustersTerminatedNCT02161185Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMUCompletedNCT01999777Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326272Phase 3

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)TerminatedNCT02829827Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy VolunteersCompletedNCT02879877Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese SubjectsCompletedNCT03605082Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily LifeCompletedNCT02354105

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms ManagementCompletedNCT03103919Phase 4

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyCompletedNCT02495844Phase 2

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UCB0107 in Healthy Male SubjectsCompletedNCT03464227Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian SubjectsCompletedNCT03168984Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male SubjectsCompletedNCT03204474Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male SubjectsCompletedNCT03086382Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese SubjectsCompletedNCT02972125Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• A First-In-Human Study With a Single Dose UCB4019 in Healthy VolunteersCompletedNCT02873767Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's DiseaseCompletedNCT02227355

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy VolunteersCompletedNCT02647697Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.

• Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the BloodCompletedNCT02306629Phase 1

  Sponsor listed in the registry: UCB Biopharma S.P.R.L.